Fingerprint
Dive into the research topics of 'A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically